K. Biberoğlu
ORCID: 0000-0003-3236-8742
· 11 papers in corpus
guideline
2023
This is the first guidelines for adenomyosis from the Asian Society of Endometriosis and Adenomyosis.
guideline
2023
This is the first guidelines for adenomyosis from the Asian Society of Endometriosis and Adenomyosis.
guideline
2023
This is the first guidelines for adenomyosis from the Asian Society of Endometriosis and Adenomyosis.
other
2023
OBJECTIVE: The aim of this study is to evaluate serum copper (Cu) and zinc (Zn) levels in patients with epithelial ovarian cancer and endometrioma. MATERIALS AND METHODS: We included 21 epithelial ovarian cancer patients, 47 endometrioma p…
review
2020
Objective: Endometriosis affects up to 10% of women of reproductive age, and the main goal of treatment is to relieve symptoms. Progestins have been the mainstay of endometriosis suppression, of which dienogest has become an important optio…
review
2020
Objective: Endometriosis affects up to 10% of women of reproductive age, and the main goal of treatment is to relieve symptoms. Progestins have been the mainstay of endometriosis suppression, of which dienogest has become an important optio…
2014
2012
2010
nonrandomized-trial
1991
The authors examined the effect and tolerability of buserelin in 40 women with endometriosis and ten women with uterine leiomyoma. Buserelin was given intranasally, 200 micrograms three times a day for 6 months. Laparoscopy was performed be…
other
1981
The use of danazol (Danocrine) appears to be the most effective medical form of therapy for endometriosis. A double-blind study on 32 patients with laparoscopically proved pelvic endometriosis was designed to evaluate the immediate short-te…